Oye Mintsa Mi-mba M-F., Jegou D., Caron V., Galarneau J., Tremblay C., Beaulieu L., Calon F. (2023) Investigating the benefits of Palmaria Palmata seaweed: Effects of its bioactive compounds on cognitive health. BénéfiQ2023, Quebec City, Canada, October 5th. (Speaker)

Oye Mintsa Mi-mba M-F., Jegou D., Galarneau J., Beaulieu L., Calon F. (2023) Effet d’une diète enrichie en extraits de Palmaria Palmata sur un modèle animal de la maladie d’Alzheimer. Réseau Québec Maritime, Québec, Canada, June 21st. (Presenter)

Oye Mintsa Mi-mba M-F., Jegou D., Caron V., Galarneau J., Beaulieu L., Calon F. (2022) Caractérisation et étude de biodistribution des acides aminés de type mycosporines (MAAs) à partir d’extraits d’algues rouges. Pharmaceutical sciences and alimentary sciences day, Quebec City, Canada, June 16th. (Presenter)

Oye Mintsa Mi-mba M-F., Jegou D., Caron V., Galarneau J., Beaulieu L., Calon F. (2022) Caractérisation et étude de biodistribution des acides aminés de type mycosporines (MAAs) à partir d’extraits d’algues rouges. Research days of the CHU of Québec-Laval University, Québec, Canada, May 26th. (Presenter)

Jegou D.*, Oye Mintsa Mi-mba M-F.*, Caron V., Galarneau J., Beaulieu L., Calon F. (2022) Projet NeuronAlg. 89th Acfas conference, Quebec City, Canada, May 13th. (Co-speaker)

Oye Mintsa Mi-mba M-F., Landry O., François A., Traversy M- T., Tremblay C., Émond V., Bennett D. A., Buxbaum J., Calon F. (2022) Shank3: Relationship between cognitive impairment and synaptic density in a mouse model of Alzheimer’s Disease. Society for Neuroscience, San Diego (CA), USA, November 12nd-16th. (Presenter)

Oye Mintsa Mi-mba M-F., Jegou D., Caron V., Galarneau J., Beaulieu L., Calon F. (2022) Characterization and bioavailability study of mycosporine-like amino acids (MAA) from read algae extracts. Neurosymposium, Montreal, Canada, June 17th. (Presenter)

Oye Mintsa Mi-mba M-F., Jegou D., Caron V., Galarneau J., Beaulieu L., Calon F. (2021) Caractérisation et étude de biodisponibilité des acides aminés de type mycosporines (MAAs) à partir d’extraits d’algues rouges. Research day of the faculty of pharmacy of Laval University, Quebec City, Canada, Nov. 28th. (Presenter)

Oye Mintsa Mi-mba M-F., Calon F. (2021) Traitements ciblant la protéine Shank3 dans la maladie d’Alzheimer. Day of the neuroscience’s axis of the CHU of Québec- Laval University, Quebec City, Canada, Apr. 9th. (Presenter)

Oye Mintsa Mi-mba M-F., Boudrault P-L, Désilets A., Leduc R., Marsault É. (2019) Optimization of matriptase-2 inhibitors. Quebec drug research network, Bromont, Canada, Nov. 13-14. (Presenter)

Oye Mintsa Mi-mba M-F., Boudrault P-L, Désilets A., Leduc R., Marsault É. (2019) Optimization of matriptase-2 inhibitors. CSC: 102nd Canadian Chemistry Conference and Exhibition, Quebec City, Canada, June 3rd-7th. (Presenter)

Oye Mintsa Mi-mba M-F., Boudrault P-L, Désilets A., Leduc R., Marsault É. (2019) Optimisation d’inhibiteurs de matriptase-2. 19th PROTEO Annual symposium, Quebec City, Canada, May 10th. (Presenter)

Oye Mintsa Mi-mba M-F., Boudrault P-L, Désilets A., Leduc R., Marsault É. (2018) Optimisation d’inhibiteurs de matriptase-2. 3rd edition of PROTEOMEUS annual Symposium, Sherbrooke, Canada, June 8th. (Presenter)

Oye Mintsa Mi-mba M-F., Boudrault P-L, Désilets A., Leduc R., Marsault É. (2018) Optimisation d’inhibiteurs de matriptase-2. Day of the Faculty of Medicine and Health Sciences of 2nd et 3rd cycles, Sherbrooke, Canada, May 28th. (Presenter)